A selective androgen receptor modulator, S4, displays robust anti
5
$ 15.99
In stock
(548)
Product Description
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
Newly developed MEIS inhibitor selectively blocks MEISHigh prostate cancer growth and induces apoptosis - ScienceDirect
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Frontiers Androgen Regulation of the Mesocorticolimbic System and Executive Function
Structure and diversity of bacterial communities associated with
Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion
A selective androgen receptor modulator, S4, displays robust anti-cancer activity on hepatocellular cancer cells by negatively regulating PI3K/AKT/mTOR signalling pathway - ScienceDirect
RNA-binding proteins that interact with the Androgen Receptor mRNA. (a)
Cancers, Free Full-Text
Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.
Cancers, Free Full-Text
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade: Cell
